Home Latest Articles
Latest Articles
  • Ruibo JIA, Dan LU, Xiangang LI, Shanshan GONG, Haoran LYU
    Chinese Journal of Pharmaceuticals. 2023, 54(11): 1676-1679.
  • Chuqiao LIU, Peng ZHANG, Lili FU, Qiaoyu TAO, Yunliang QIU
    Chinese Journal of Pharmaceuticals. 2023, 54(10): 1403-1410.

    Inherited retinal diseases(IRD) are an important cause of irreversible vision loss or blindness, whose prognosis is poor, and clinically effective intervention methods are lacking. Gene therapy has created new possibilities for IRD treatment. Adeno-associated viral(AAV) is a widely used viral gene therapy vector with application prospects. This paper briefly describes the feasibility of AVV vectors in ocular application, focuses on the preclinical and clinical progress of the application of AAV delivery system for IRD treatment, evaluates the safety and efficacy based on the obtained data, and summarizes the influencing factors of gene therapy for IRD, as well as looks forward to the future research directions, providing references for the technological innovation of IRD treatment and the subsequent product development of AAV vectors.

  • Yan KUANG, Wenjing SU, Weike SU, Wenhao XU
    Chinese Journal of Pharmaceuticals. 2023, 54(10): 1411-1419.

    Astaxanthin, as a fat-soluble carotenoid, has strong antioxidant properties. However, its application is limited due to the poor water solubility, extreme sensitivity to temperature, light and oxygen, and low bioavailability. Nowadays, new nano drug delivery systems have advantages in improving the aforementioned defects. In this paper, the current research status and application of astaxanthin nano preparations based on lipid, polysaccharide and protein are reviewed. Then, the directions of research on astaxanthin nano delivery systems are generalized and contemplated, hoping to provide references for the future clinical application of astaxanthin.

  • Yang CAO, Ranran ZHU, Xingjun OU, Lixing SONG, Fanhong WU
    Chinese Journal of Pharmaceuticals. 2023, 54(10): 1420-1428.

    Chirality is a widely existing property in pharmaceuticals. In general, the chiral enantiomers show higher activity and lower adverse reaction than their racemates. Therefore, the manufacturing of pure chiral enantiomer is of great scientific significance. Crystallization resolution method is an important technique in pharmaceutical industry to achieve the separation of enantiomers. As a novel crystallization technique, cocrystal has attracted much attention due to its broad applicability. In this paper, the history and development of chiral resolution based on cocrystallization are briefly introduced. Meanwhile, the recent progress in this field is classified and summarized according to the structural characteristics of cocrystals formed by racemic drugs. In addition, the main challenges of chiral resolution based on cocrystallization are summarized and prospected.

  • Zhe SUN, Xiangyang XU, Xiangping YANG, Hui WANG, Le ZHANG
    Chinese Journal of Pharmaceuticals. 2023, 54(10): 1429-1432.

    Tiapride hydrochloride was synthesized from 2-methoxy benzoic acid with an overall yield of 46.0% by the reaction with chlorosulfonic acid, followed by sodium sulfite and dimethylsulfate to generate methyl 2-methoxy-5-(methanesulfonyl) benzoate, the latter was reacted with N, N-diethylenediamine, and then by salt formation with hydrochloric acid.

  • Zhen ZHANG, Wenting XIAO, Yanli GUO, Guan WANG, Jianqi LI
    Chinese Journal of Pharmaceuticals. 2023, 54(10): 1433-1435.

    Ivabradine hydrochloride is the first selective and specific inhibitor of sinus node If current, which is mainly used for the treatment of stable angina pectoris. Compound l-methylamino-4,5-dimethoxybenzocyclobutane(3) is the key intermediate in the synthetic route of ivabradine hydrochloride, which is obtained by reduction of 1-cyano-4,5-dimethoxybenzocyclobutane(2) in the traditional high-pressure hydrogenation kettle. In this paper, a continuous flow microreactor was used to replace the hydrogenation kettle. In the ammonia-methanol solution, the optimized conditions were determined as follows: Raney nickel as the catalyst, the concentration of compound 2 was 0.5 mol/L, the temperature was 41 - 47 ℃, and the flow rate was 8 mL/min. The total yield reached 99.83% and the purity of compound 3 was 99.58%, laying the foundation for the scale-up of the pilot scale.

  • Aibo LI, Dong PEI
    Chinese Journal of Pharmaceuticals. 2023, 54(10): 1436-1441.

    Degradation products are the common impurities of some aminoglycoside antibiotics, and their residue definitions are strictly controlled in the pharmacopoeia. In this paper, the synthesis methods of degradation impurities of tobramycin, sisomicin, netilmicin, kanamycin and amikacin were investigated. Four primary degradation impurities and one common secondary degradation product were prepared by acid hydrolysis or derivative oxidation with HPLC purity of more than 95%. The structures of aforementioned five compounds were confirmed by 1H NMR and LC-MS, which could be used as the references for the quality control of the aminoglycoside antibiotics.

  • Ganglong JIANG, Xiaowen ZHANG, Dongshuo MENG, Wenshuang DIAO, Yu LIU
    Chinese Journal of Pharmaceuticals. 2023, 54(10): 1442-1449.

    To perform the quality control of lifitegrast(1), five process impurities were prepared. These substances were (S)-2-amino-3-[3-(methylsulfonyl)phenyl]propanoic acid hydrochloride(related substance A), 6-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)-2-(tert-butyl) 5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-2,6-dicarboxylate(related substance B), ethyl (S)-2-(5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-[3-(methylsulfonyl)phenyl]-propanoate hydrochloride(related substance C), (S)-2-(5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-[3-(methylsulfonyl)phenyl]propanoic acid hydrochloride(related substance D), 2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid(related substance E). The related substances B and C had not been reported in the literature. Meanwhile, seven corresponding isomeric intermediates were synthesized in the preparation of (R)-1. They could be used as the reference substances for the quality control of 1.

  • Qing MA, Meixi JIN, Xiaoli WANG, Yong GAN
    Chinese Journal of Pharmaceuticals. 2023, 54(10): 1450-1458.

    Lutein ester(1) submicron emulsion was prepared via high-speed shear high-pressure homogenization method, and further combined with freeze-drying method to prepare 1 freeze-dried submicron emulsion. The freeze-dried submicron emulsion of 1(F-1-SME) demonstrated good uniformity, with a particle size of (181.33±1.29)nm and an encapsulation efficiency of (97.17±0.79)%. The F-1-SME maintained good stability(with a content decrease no more than 5% within 10 days) under high temperature, high humidity, and strong light conditions, and it was stable in simulated gastrointestinal fluid for at least 24 hours. After being treated with simulated gastrointestinal fluid, (72.95±0.05)% of 1 was detected dissolving in the aqueous phase, indicating that the submicron emulsion still had a certain solubilizing effect on 1 after exposure to gastrointestinal fluid, which was conducive to enhancing oral absorption. Furthermore, pharmacokinetic test results of F-1-SME in rats showed that the cmax in rat plasma and AUC0→24 h of F-1-SME group were 2.7- and 2.8-times higher than those of the commercially available tablets group after gavage administration of the same dose, indicating a significant increase in the oral bioavailability of F-1-SME. Finally, in a rat model of retinal blue light-induced damage, oral administration of the F-1-SME demonstrated effective protection of retinal cells, indicating its potential for protecting retinal from blue light damage.

  • Liang KONG, Ruibo GUO, Lu ZHANG, Xuetao LI, Lianqun JIA
    Chinese Journal of Pharmaceuticals. 2023, 54(10): 1459-1466.

    Glycyrrhetinic acid(GA) modified enzyme sensitive doxorubicin(1) liposomes(GA-1-PVGLIG-Lip) were prepared by thin film dispersion-ammonium sulfate gradient method. The Box-Behnken design-response surface methodology was used to optimize the formulation and process parameters, with the encapsulation rate of 1 as an index, and the mass ratio of phospholipid-to-cholesterol(EPC-to-Chol), the mass ratio of EPC-to-1 and the hydration time as independent variables. Then, the response ability of the liposomes to matrix metalloproteinase 2(MMP-2) and the targeting effect in vitro on liver cancer stem cells(LCSCs) were investigated. The results showed that the optimized formulation and process parameters were as follows: EPC-to-Chol mass ratio of 6.88, EPC-to-1 mass ratio of 27.74, and hydration time of 35.12 min. The average encapsulation rate of the obtained optimal liposomes reached (92.58±0.92)%. In conclusion, the GA-1-PVGLIG-Lip had a good MMP-2 response and showed a significant targeting ability to LCSCs in the presence of MMP-2. In this study, MMP-2-responsive liposomes targeting to LCSCs were successfully prepared, which provided a new strategy for hepatocellular carcinoma treatment.

News